Literature DB >> 24320433

Is ExacTrac x-ray system an alternative to CBCT for positioning patients with head and neck cancers?

Stefania Clemente1, Costanza Chiumento, Alba Fiorentino, Vittorio Simeon, Mariella Cozzolino, Caterina Oliviero, Giorgia Califano, Rocchina Caivano, Vincenzo Fusco.   

Abstract

PURPOSE: To evaluate the usefulness of a six-degrees-of freedom (6D) correction using ExacTrac robotics system in patients with head-and-neck (HN) cancer receiving radiation therapy.
METHODS: Local setup accuracy was analyzed for 12 patients undergoing intensity-modulated radiation therapy (IMRT). Patient position was imaged daily upon two different protocols, cone-beam computed tomography (CBCT), and ExacTrac (ET) images correction. Setup data from either approach were compared in terms of both residual errors after correction and punctual displacement of selected regions of interest (Mandible, C2, and C6 vertebral bodies).
RESULTS: On average, both protocols achieved reasonably low residual errors after initial correction. The observed differences in shift vectors between the two protocols showed that CBCT tends to weight more C2 and C6 at the expense of the mandible, while ET tends to average more differences among the different ROIs.
CONCLUSIONS: CBCT, even without 6D correction capabilities, seems preferable to ET for better consistent alignment and the capability to see soft tissues. Therefore, in our experience, CBCT represents a benchmark for positioning head and neck cancer patients.

Entities:  

Mesh:

Year:  2013        PMID: 24320433     DOI: 10.1118/1.4824056

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  7 in total

Review 1.  Image-guided radiation therapy (IGRT): practical recommendations of Italian Association of Radiation Oncology (AIRO).

Authors:  Paola Franzone; Alba Fiorentino; Salvina Barra; Domenico Cante; Laura Masini; Elena Cazzulo; Liana Todisco; Pietro Gabriele; Elisabetta Garibaldi; Anna Merlotti; Maria Grazia Ruo Redda; Filippo Alongi; Renzo Corvò
Journal:  Radiol Med       Date:  2016-09-06       Impact factor: 3.469

2.  Reducing ExacTrac intrafraction imaging uncertainty for prostate stereotactic body radiotherapy using a pre-treatment CBCT.

Authors:  Barry Jordan; Luis Muñoz; Christopher Colyer
Journal:  Phys Eng Sci Med       Date:  2022-04-19

3.  Estimating PTV Margins in Head and Neck Stereotactic Ablative Radiation Therapy (SABR) Through Target Site Analysis of Positioning and Intrafractional Accuracy.

Authors:  Shane Mesko; He Wang; Samuel Tung; Congjun Wang; Dario Pasalic; Bhavana V Chapman; Amy C Moreno; Jay P Reddy; Adam S Garden; David I Rosenthal; G Brandon Gunn; Steven J Frank; Clifton D Fuller; William Morrison; Jack Phan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-09-30       Impact factor: 7.038

4.  Estimation of effective imaging dose and excess absolute risk of secondary cancer incidence for four-dimensional cone-beam computed tomography acquisition.

Authors:  Yuki Yuasa; Takehiro Shiinoki; Ryota Onizuka; Koya Fujimoto
Journal:  J Appl Clin Med Phys       Date:  2019-10-08       Impact factor: 2.102

5.  The influence of a six degrees of freedom couch and an individual head support in patient positioning in radiotherapy of head and neck cancer.

Authors:  Myra F Rodrigues; Sten Veen; Jaap van Egmond; Mark van Hameren; Theodorus van Oorschot; Steven de Vet; Jan P C van Santvoort; Ruud G J Wiggenraad; Mirjam E Mast
Journal:  Phys Imaging Radiat Oncol       Date:  2019-07-26

6.  Setup error assessment based on "Sphere-Mask" Optical Positioning System: Results from a multicenter study.

Authors:  Yan Zhang; Han Zhou; Kaiyue Chu; Chuanfeng Wu; Yun Ge; Guoping Shan; Jundong Zhou; Jing Cai; Jianhua Jin; Weiyu Sun; Ying Chen; Xiaolin Huang
Journal:  Front Oncol       Date:  2022-10-04       Impact factor: 5.738

7.  The impact of the three degrees-of-freedom fiducial marker-based setup compared to soft tissue-based setup in hypofractionated intensity-modulated radiotherapy for prostate cancer.

Authors:  Satoshi Tanabe; Satoru Utsunomiya; Eisuke Abe; Hiraku Sato; Atsushi Ohta; Hironori Sakai; Takumi Yamada; Motoki Kaidu; Hidefumi Aoyama
Journal:  J Appl Clin Med Phys       Date:  2019-05-04       Impact factor: 2.102

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.